Transglutaminase IgG at Dr. Essa Lab

Transglutaminase IgG at Dr. Essa Lab

The Transglutaminase IgG (tissue Transglutaminase Immunoglobulin G or tTG-IgG) test is a highly specialized serological laboratory investigation used primarily in the diagnostic workup of celiac disease. Celiac disease is a serious, genetically linked autoimmune enteropathy triggered by the ingestion of gluten, a protein composite found in wheat, barley, and rye. When individuals with celiac disease consume gluten, their immune system mounts an abnormal response that targets the mucosal lining of the small intestine. Tissue transglutaminase is a complex intracellular enzyme responsible for repairing tissue and cross-linking specific proteins. During the autoimmune cascade triggered by gluten, the body produces autoantibodies directed against this enzyme. The Transglutaminase IgG test measures the concentration of these specific IgG class autoantibodies in the patient’s blood serum.

While the tissue Transglutaminase IgA (tTG-IgA) antibody test is widely recognized as the primary screening tool for celiac disease due to its high sensitivity and specificity, the Transglutaminase IgG test plays an indispensable clinical role. Approximately 2% to 3% of patients with celiac disease suffer from selective immunoglobulin A (IgA) deficiency, a condition that is ten to fifteen times more prevalent in celiac patients than in the general population. In these IgA-deficient individuals, tests measuring IgA antibodies will yield false-negative results, potentially delaying crucial medical intervention. Therefore, the Transglutaminase IgG test serves as the gold-standard alternative and complementary diagnostic tool, ensuring accurate detection of celiac disease in patients with low or absent baseline IgA levels.

At Dr. Essa Laboratory & Diagnostic Centre, a premier diagnostic institution in Pakistan, this test is performed using advanced, fully automated enzyme-linked immunosorbent assay (ELISA) or chemiluminescent immunoassay (CLIA) technologies. These state-of-the-art platforms ensure exceptional analytical sensitivity and specificity, providing clinical teams with highly precise quantitative measurements. Evaluating the levels of tTG-IgG is clinically vital not only for establishing an initial diagnosis of celiac disease but also for monitoring dietary compliance and assessing mucosal healing in patients undergoing treatment with a strict gluten-free diet.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is paramount to ensure the clinical validity of the Transglutaminase IgG test. The most critical preparation requirement is the maintenance of a normal, gluten-containing diet prior to sample collection. Patients must not initiate a gluten-free diet before undergoing this test. If gluten has been eliminated or significantly restricted from the diet, the immune system stops producing the target autoantibodies, which can lead to a false-negative result. Clinical guidelines generally recommend that patients consume at least one to two meals containing gluten daily for six to eight weeks before the blood draw to ensure accurate antibody detection. If a patient has already transitioned to a gluten-free diet, a supervised gluten challenge may be required under the direction of a gastroenterologist. No overnight fasting is strictly required for this test, though patients should remain well-hydrated. It is also essential to inform the healthcare provider of all current medications, immunosuppressive therapies, and pre-existing autoimmune conditions, as these can influence systemic antibody production.

During the Procedure

The Transglutaminase IgG test is a standard venipuncture procedure performed by highly trained phlebotomists at Dr. Essa Lab. The patient is comfortably seated, and the phlebotomist identifies a suitable vein, typically in the antecubital fossa of the arm. The skin over the selected vein is thoroughly cleansed with an antiseptic solution to prevent contamination. A sterile, single-use needle is gently inserted into the vein to collect a small volume of blood into a gold-top or red-top serum separator tube (SST). The entire collection process takes less than five minutes and involves minimal discomfort, often described as a brief pinching sensation. Once the sample is obtained, pressure is applied to the puncture site with a sterile cotton ball, and a bandage is applied to prevent bruising. The collected blood sample is then allowed to clot before being centrifuged to separate the serum. The serum is carefully aliquoted and transferred to the immunology department for automated analysis under strict quality control protocols.

When is a Transglutaminase IgG Performed?

Screening for Celiac Disease in IgA-Deficient Patients

Physicians routinely order the Transglutaminase IgG test when screening for celiac disease in individuals known to have selective IgA deficiency. Because the standard screening panel relies heavily on IgA-based antibodies, an underlying IgA deficiency would render those tests completely non-reactive, despite the presence of severe intestinal damage. By evaluating the IgG class of antibodies, clinicians can bypass this diagnostic limitation, obtaining a reliable immunological profile that accurately reflects the patient’s autoimmune reactivity to gluten.

Evaluation of Chronic Gastrointestinal Symptoms

This investigation is frequently requested for patients presenting with persistent, unexplained gastrointestinal distress. Common symptoms prompting this test include chronic diarrhea, abdominal pain, bloating, flatulence, persistent nausea, vomiting, and altered bowel habits. When these symptoms do not resolve with standard symptomatic treatments, a systemic autoimmune etiology such as celiac disease must be investigated, and the Transglutaminase IgG test serves as a key non-invasive diagnostic step.

Investigation of Unexplained Malabsorption and Weight Loss

Unexplained weight loss, nutritional deficiencies, and signs of malabsorption are strong clinical indications for this test. When the small intestinal villi are damaged by an autoimmune reaction, the body’s ability to absorb essential nutrients is severely compromised. This can lead to iron-deficiency anemia unresponsive to oral iron supplementation, vitamin D deficiency, osteoporosis, chronic fatigue, and failure to thrive or short stature in pediatric patients. The Transglutaminase IgG test helps identify if gluten-induced enteropathy is the root cause of this malabsorptive state.

Monitoring Adherence to a Gluten-Free Diet

For patients with a confirmed diagnosis of celiac disease, the Transglutaminase IgG test is an effective tool for long-term monitoring. After adopting a strict gluten-free diet, antibody levels in the blood should gradually decline over several months. Periodic testing allows gastroenterologists to assess compliance with the dietary regimen, identify accidental gluten exposure, and confirm immunological remission. Persistent elevation of tTG-IgG levels may indicate ongoing dietary contamination or, in rare cases, refractory celiac disease.

Assessment of High-Risk Pediatric Patients

Pediatricians frequently utilize this test to evaluate infants and children who exhibit symptoms of malabsorption, chronic abdominal distension, irritability, delayed puberty, or unexplained growth failure. Early and accurate diagnosis of celiac disease in children is critical to prevent long-term developmental delays, nutritional deficiencies, and bone density issues. The high sensitivity of the automated testing at Dr. Essa Lab provides pediatricians with the reliable data needed to make timely clinical decisions.

What Does a Transglutaminase IgG Detect?

The Transglutaminase IgG test is designed to detect and quantify specific immunological markers and clinical states, including:

• Elevated levels of IgG autoantibodies directed against tissue transglutaminase enzymes.
• Active autoimmune enteropathy triggered by dietary gluten consumption.
• Potential selective IgA deficiency when analyzed alongside a total IgA control test.
• Gluten-sensitive enteropathy in patients who test negative for IgA-class antibodies.
• The immunological response associated with dermatitis herpetiformis, a skin manifestation of celiac disease.
• The presence of systemic autoimmune activity localized within the gastrointestinal tract.
• Progressive mucosal damage and villous atrophy within the duodenum and jejunum.
• Efficacy of dietary interventions, demonstrated by a decrease in antibody titers over time.
• Accidental or hidden gluten exposure in patients attempting to maintain a gluten-free diet.
• Potential refractory celiac disease in patients with persistently high antibody levels despite dietary compliance.
• Increased probability of celiac disease in genetically predisposed individuals (HLA-DQ2 or HLA-DQ8 positive).
• The need for a confirmatory upper gastrointestinal endoscopy and duodenal biopsy.
• Risk of associated autoimmune conditions, such as Type 1 Diabetes or autoimmune thyroiditis.
• Asymptomatic or silent celiac disease in individuals with a strong family history.
• Malabsorption risk factors linked to autoimmune-mediated intestinal epithelial damage.
• Immunological cross-reactivity associated with chronic inflammatory bowel conditions.
• Subclinical intestinal inflammation prior to the onset of severe structural villous atrophy.
• Serological baseline values prior to initiating a therapeutic gluten challenge.
• The presence of extra-intestinal manifestations of gluten sensitivity, such as neurological symptoms or ataxia.
• The underlying cause of unexplained, refractory iron-deficiency anemia.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Laboratory & Diagnostic Centre is committed to delivering accurate diagnostic results with optimal efficiency. The turnaround time for the Transglutaminase IgG test is typically within 24 to 48 hours from the time of sample collection. Because this specialized immunological assay requires precise calibration and quality control checks, our expert pathologists oversee each run to ensure maximum clinical accuracy. Once the analysis is complete, reports are immediately verified and uploaded to our secure digital database. Patients and referring physicians can easily access, download, and print reports online through the Dr. Essa Lab web portal or mobile application. Additionally, patients receive an automated SMS notification containing a direct link to their digital report as soon as it is authorized, eliminating unnecessary wait times and facilitating prompt clinical consultation.

Transglutaminase IgG Findings Overview

The following table outlines the clinical parameters evaluated during a Transglutaminase IgG test, along with typical normal and abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
tTG-IgG Antibody Level	Negative (typically < 6.0 U/mL, depending on assay kit)	Positive (Elevated levels ≥ 6.0 U/mL), indicating active autoimmune response
Total Serum IgA Level	Within age-specific reference intervals	Decreased or undetectable levels, confirming selective IgA deficiency
Small Intestinal Mucosa	Intact villi, normal crypt depth, no intraepithelial lymphocytosis	Villous atrophy, crypt hyperplasia, increased intraepithelial lymphocytes (indicative of celiac disease)
Dietary Gluten Status	No antibody production in the absence of gluten (or during successful GFD)	Elevated antibody levels due to active gluten consumption or accidental exposure
Clinical Symptoms Correlation	Absence of gastrointestinal or systemic symptoms	Chronic diarrhea, abdominal pain, weight loss, and severe nutritional deficiencies
Nutrient Absorption Capacity	Normal absorption of iron, folate, vitamin B12, and fat-soluble vitamins	Malabsorption leading to anemia, osteoporosis, and metabolic bone disease
Extra-intestinal Manifestations	Healthy skin, normal neurological function, no joint pain	Dermatitis herpetiformis, gluten ataxia, peripheral neuropathy, or aphthous stomatitis

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Transglutaminase IgG?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, immunologists, and technologists specializing in autoimmune diagnostics.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Dr. Essa Lab adheres to strict international quality standards, utilizing ISO-certified protocols to ensure clinical precision.
• Professional Reporting: Our diagnostic reports are comprehensive, easy to read, and structured to provide clear clinical guidance to your physician.
• Modern Diagnostic Approach: We utilize state-of-the-art automated ELISA and CLIA analyzers to eliminate human error and enhance sensitivity.
• Comfortable Environment: Our diagnostic centers across Pakistan offer clean, hygienic, and welcoming environments for all patients.
• Convenient Location: With an extensive network of branches in Karachi and other major cities, accessing our services is highly convenient.
• Commitment to Accurate Diagnosis: We understand the impact of accurate diagnostics on patient lives and are dedicated to delivering results you can trust.